written on 13.03.2014

Proposals seek 'appropriate and transparent' Japan investigator studies


"The guidance is in fact already being followed by most [PhRMA member] companies in Japan, and we see it as very solid and transparent," he said. As to whether the proposals might form the basis of an industry-wide plan, Mr Alvarez added: "There is a lot…